Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity

SIMPLE SUMMARY: The residual cancer burden (RCB) score provides prognostic information on the survival of breast cancer patients who underwent neoadjuvant systemic therapy, with the greatest impact of higher scores on worse recurrence-free survival (RFS) and overall survival (OS) in triple-negative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Suppan, Christoph, Posch, Florian, Mueller, Hannah Deborah, Mischitz, Nina, Steiner, Daniel, Klocker, Eva Valentina, Setaffy, Lisa, Bargfrieder, Ute, Hammer, Robert, Hauser, Hubert, Jost, Philipp J., Dandachi, Nadia, Lax, Sigurd, Balic, Marija
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161089/
https://ncbi.nlm.nih.gov/pubmed/34065332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102492
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars